Literature DB >> 9367292

Acupuncture and the opioid system: implications in management of migraine.

S Pintov1, E Lahat, M Alstein, Z Vogel, J Barg.   

Abstract

We investigated the effectiveness of acupuncture in childhood migraine in 22 children with migraine, randomly divided into two groups: a true acupuncture group (12 children) and a placebo acupuncture group (10 children). Ten healthy children served as a control group. Opioid activity in blood plasma was assayed by two methods: (1) determination of total (panopioid) activity with an opiate radioreceptor assay, and (2) determination of beta-endorphinlike immunoreactivity by radioimmunoassay. The true acupuncture treatment led to significant clinical reduction in both migraine frequency and intensity. At the beginning of the study, significantly greater panopioid activity was evident in plasma of the control group than in plasma of the migraine group. The true acupuncture group showed a gradual increase in the panopioid activity in plasma, which correlated with the clinical improvement. After the tenth treatment, the values of opioid activity of the true acupuncture group were similar to those of the control group, whereas the plasma of the placebo acupuncture group exhibited insignificant changes in plasma panopioid activity. In addition, a significant increase in beta-endorphin levels was observed in the migraine patients who were treated in the true acupuncture group as compared with the values before treatment or with the values of the placebo acupuncture group. The results suggest that acupuncture may be an effective treatment in children with migraine headaches and that it leads to an increase in activity of the opioidergic system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367292     DOI: 10.1016/s0887-8994(97)00086-6

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  19 in total

Review 1.  Acupuncture.

Authors:  A Vickers; P Wilson; J Kleijnen
Journal:  Qual Saf Health Care       Date:  2002-03

2.  Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome.

Authors:  Adeline X Y Ge; Mary E Ryan; Steven M Holland; Alexandra F Freeman; Victoria L Anderson; Fei Wang; Jim W Fleshman
Journal:  J Altern Complement Med       Date:  2011-01-05       Impact factor: 2.579

3.  Effectiveness of acupuncture for treatment of childhood constipation.

Authors:  E Broide; S Pintov; S Portnoy; J Barg; E Klinowski; E Scapa
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 4.  Tension-type headache in children and adolescents.

Authors:  Pirjo Anttila
Journal:  Curr Pain Headache Rep       Date:  2004-12

5.  Use of low-energy laser as adjunct treatment of alcohol addiction.

Authors:  Jadwiga Zalewska-Kaszubska; Dominik Obzejta
Journal:  Lasers Med Sci       Date:  2004       Impact factor: 3.161

6.  A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution.

Authors:  Kit Lu; Mok-Chung Jennifer Cheng; Xiaoying Ge; Ann Berger; Dihua Xu; Gregory J Kato; Caterina P Minniti
Journal:  Clin J Pain       Date:  2014-09       Impact factor: 3.442

Review 7.  Commentary on the use of acupuncture in chronic pediatric pain.

Authors:  Michael Waterhouse; Jennie C I Tsao; Lonnie K Zeltzer
Journal:  J Dev Behav Pediatr       Date:  2009-02       Impact factor: 2.225

8.  Yoga for youth in pain: the UCLA pediatric pain program model.

Authors:  Subhadra Evans; Mona Moieni; Beth Sternlieb; Jennie C I Tsao; Lonnie K Zeltzer
Journal:  Holist Nurs Pract       Date:  2012 Sep-Oct       Impact factor: 1.000

9.  Paediatric Pain Management: Using Complementary and Alternative Medicine.

Authors:  Subhadra Evans; Jennie C I Tsao; Lonnie K Zeltzer
Journal:  Rev Pain       Date:  2008-09

10.  Pediatric acupuncture: a review of clinical research.

Authors:  Jeffrey I Gold; Colette D Nicolaou; Katharine A Belmont; Aaron R Katz; Daniel M Benaron; Wendy Yu
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.